Transgenic mice carrying Hp-2 gene and uses as models for vascular diseases

Details for Australian Patent Application No. 2006268327 (hide)

Owner Rappaport Family Institute for Research in The Medical Sciences

Inventors Levy, Andrew; Levy, Nina

Agent Griffith Hack

Pub. Number AU-A-2006268327

PCT Pub. Number WO2007/008870

Priority 60/698,012 12.07.05 US

Filing date 12 July 2006

Wipo publication date 18 January 2007

International Classifications

C12P 21/00 (2006.01) Preparation of peptides or proteins

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2007/008870 Priority application(s): WO2007/008870

24 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006268333-Compositions and methods for eliciting an immune response to escape mutants of targeted therapies

2006268326-Methods of dosing propofol prodrugs for inducing mild to moderate levels of sedation